Case-control study on risk factors of narcolepsy in Germany;Fall-Kontroll-Studie zu Risikofaktoren von Narkolepsie in Deutschland

Somnologie

Volumn 17, Issue 1, 2013, Pages 39-48

  Oberle, D ^a   Ponisch C ^a   Mayer, G ^b   Keller Stanislawski, B ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adverse drug event; Case control studies; Influenza vaccines; Narcolepsy; Pandemics

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; GERMANY; HUMAN; NARCOLEPSY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SCHOOL CHILD; SLEEP; VACCINATION;

EID: 84877580011     PISSN: 14329123     EISSN: 1439054X     Source Type: Journal    
DOI: 10.1007/s11818-013-0604-2     Document Type: Review

References (30)

1. AASM (American Academy of Sleep Medicine) (2005) International classification of sleep disorders, ICSD 2 diagnostic and coding manual. Westchester
2. Berner R, Bialek R, Forster J (2004) Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland (ESPED). Monatsschr Kinderheilk 152:7779
3. Choe YJ, Bae GR, Lee DH (2012) No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 30:7439-7442
4. Deutsche Gesellschaft für Neurologie. AWMF-Leitlinien-Register. Nr. 030/056: "Narkolepsie". http://www.awmf.org/uploads/tx-szleitlinien/ 030-056-S1-Narkolepsie-10-2008-10-2013.pdf
5. Europäische Arzneimittelagentur (EMA). Empfehlung der Europäischen Arzneimittelagentur EMA, die Anwendung des pandemischen Impfstoffs Pandemrix bei Personen unter 20 Jahren einzuschränken. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2011/07/ news-detail-001312.jsp&murl=menus/news-and-events/news-and-events. jsp&mid=WC0b01ac058004d5c1
6. European Centre for Disease Control and Prevention. Narcolepsy in association with pandemic influenza vaccination - a multi-country European epidemiological investigation. http://www.ecdc.europa.eu/en/publications/ Publications/Forms/ECDC-DispForm.aspx?ID=959
7. Fontana A, Gast H, Reith W, et al. (2010) Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133:1300-1311
8. Greenland S (2001) Ecologic versus individual-level sources of bias in ecologic estimates of contextual health effects. Int J Epidemiol 30:1343-1350 (Pubitemid 34134288)
9. Han F, Lin L, Warby SC, et al. (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70:410-417
10. Handwerker G (2005) Narkolepsie im Kindes- und Jugendalter. Monatsschr Kinderheilk 2:153
11. Kawashima M, Tamiya G, Oka A, et al. (2006) Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 79:252-263 (Pubitemid 44141824)
12. Longstreth WT Jr, Koepsell TD, Ton TG, et al. (2007) The epidemiology of narcolepsy. Sleep 30:13-26 (Pubitemid 46098865)
13. Mayer G (2006) Narkolepsie Taschenatlas spezial. Georg Thieme, Stuttgart
14. Menhard S (2009) Logistic regression: from introductory to adVanced concepts and applications. Sage Publications Ltd, Thousand Oaks
15. MPA. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations. Results of a case inventory study by the MPA in Sweden during 2009-2010. http://www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport- pandermrix-110630.pdf
16. National Narcolepsy Steering Committee. Pressemitteilung zum Final Report of the National Narcolepsy Study Steering Committee. http://www.dohc.ie/press/ releases/2012/20120419.html
17. National Narcolepsy Study Steering Committee. Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. http://www.dohc.ie/publications/Nat-Narcolespy-Study-SC-Report.html
18. Nohynek H, Jokinen J, Partinen M, et al. (2012) AS03 adjuVanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7:e33536
19. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7:e33723
20. Saltelli A, Chan K, Scott EM (Hrsg) (2009) Sensitivity analysis. John Wiley & Sons Ltd, Chichester
21. Service de pharmacologie (INSERM CIC-P 0005 Pharmaco-Epidémiologie Segalen - CHU de Bordeaux. Etude NarcoFlu-VF (NarcoFlu VAESCO-France): Grippe, vaccination antigrippale et narcolepsie: contribution française à l'étude cas-témoins européenne. Août 2012. (20/09/2012). http://ansm.sante.fr/S-informer/Actualite/Vaccins-pandemiques- grippe-A-H1N1-et-narcolepsie-Resultats-de-l-etude-europeenne-et-de-l-etude-cas- temoins-francaise-Point-d-information
22. Smith AJ, Jackson MW, Neufing P, et al. (2004) A functional autoantibody in narcolepsy. Lancet 364:2122-2124 (Pubitemid 39626808)
23. THL. Association between Pandemrix and narcolepsy confirmed among Finnish children and adolescents. http://www.thl.fi/en-US/web/en/pressrelease?id=26352
24. THL. Kansallisen narkolepsia - työryhmän loppuraportti 31-Aug-2011. http://www.thl.fi/thl-client/pdfs/c02a3788-a691-47a4-bca8- 5161b6cff077
25. THL. National Narcolepsy Task force Interim Report 31-Jan-2011. http://www.thl.fi/thl-client/pdfs/dce182fb-651e-48a1-b018-3f774d6d1875
26. Wijnans L, Lecomte C, Vries C de, et al. (2012) The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31:1246-1254
27. Lin L, Nishino S, Zeitzer J, Bassetti C, et al. (2006) Guidelines for the appropriate use of CSF measurements to diagnose narcolepsy and accreditation of measurements sites. In Bassetti C, Billiard M, Mignot E (eds). In: Narcolepsy and Hypersomnia, 1st edition, Informa Healthcare, New York, London
28. Littner MR, Kushida, C, Wise M, et al. (2005) Practice parameters for clinical use of the multiple sleep latency test and maintenance of wakefulness test. Sleep; 28:113-121 (Pubitemid 40543126)
29. Guilleminault C, Pelayo R. (2000) Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up. Pediatr Drugs;2:1-9 (Pubitemid 30082315)
30. Serra L, Montagna P, Mignot E, et al. (2008) Cataplexy features in childhood narcolepsy. Mov Disord. Apr 30; 23(6):858-65